# BioCardia Beats Q3 GAAP Loss Per Share Estimate by One Cent

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56963
Published: 2026-11-13T18:45:43.000Z
Updated: 2026-11-13T18:45:43.000Z
Section: Business

> Net cash used in operations was $1.7 million, matching the year-earlier quarter.

BioCardia, Inc. (NASDAQ: BCDA) posted a GAAP loss of $0.12 per share for the third quarter of 2026, beating the estimate by $0.01.

Net cash used in operations was $1.7 million for the three months ended September 2026, matching the $1.7 million recorded in the same period in 2025.